Journal
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
Volume 71, Issue -, Pages 21-47Publisher
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.neubiorev.2016.08.032
Keywords
Attention-deficit/hyperactivity disorder (ADHD); Intelligence; High IQ; Gifted; Validity; Behavior; Hyperactivity; Cognition; Imaging; Testosterone; Lateralization; Maturation
Categories
Funding
- Arbor
- Pfizer
- Ironshore
- Shire
- Akili Interactive Labs
- CogCubed
- Alcobra
- VAYA Pharma
- Neurovance
- Impax
- NeuroLifeSciences
Ask authors/readers for more resources
The validity of Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals with high intelligence is disputed, since high intelligence may 'mimic' the symptoms of ADHD in the absence of the specific pathophysiological pathways for ADHD. Conversely, increased risk of a missed ADHD diagnosis may occur due to compensatory strategies in the highly intelligent individual. A systematic literature review was performed including cognitive and behavioral studies, addressing a specific set of criteria for validating ADHD in the context of high intelligence. Albeit limited in number, available results suggest that ADHD is a valid construct in the context of high intelligence, showing characteristic clinical features (except possibly for hyperactivity being a less specific pathology marker), course and outcome and a characteristic response to treatment. Importantly, ADHD and IQ are negatively correlated on nearly all phenotypic and cognitive constructs, underlining the need for taking IQ into account as potential moderator in ADHD studies and more systematically studying ADHD in the high intelligent population. (C) 2016 Elsevier Ltd. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available